Critics of Cineplex Inc. (TSX:CGX) have long held that the company’s over-reliance on theatre admissions and concessions is bound to have a revenue-limiting impact on Cineplex over the long term.
While there is an argument to support that theory — Cineplex took steps to reduce the dependency on Hollywood –there is still plenty to love about this entertainment company.
Let’s take a closer look at what critics point to as issues and why they aren’t as dire as suggested.
The movie-and-popcorn model
The traditional movie-and-popcorn model has evolved over the past few decades, but hasn’t really changed much. That model is still based on charging an admission to see a show and then offering concessions during the show.
One continued concern among investors and analysts alike is that given the emergence of nearly unlimited streaming and viewing options, why would people continue to visit Cineplex’s theatres?
There are two issues with this criticism that come down to exclusivity and experience.
Regardless of how many screening options are at our disposal, there’s still a window of time following the release of a movie when it’s almost exclusively screened in theatres. Thanks to our growing fascination and use of connected devices and smartphones, we’re now conditioned to expect to get what we want without waiting for it.
To put it another way, waiting more than three months to watch The Last Jedi on a streaming device doesn’t satisfy our instant need to see it, whereas going to the theatre today does.
Second, watching a movie is a very different experience in the theatre vs. watching it on your phone. Cineplex has enhanced the movie experience in recent years, converting theatres to the newer VIP experience offering. The VIP experience includes larger leather recliners, wine lists and an upgraded concession menu worthy of inclusion at many restaurants.
In other words, buying a movie ticket has become more of a holistic entertainment experience rather than just a movie.
The summer blockbuster season wasn’t as weak as many expected
Theatre revenues are still very dependent on Hollywood’s latest blockbusters, which tend to cluster around the summer period from the end of May through the end of August.
During the most recent summer blockbuster season, critics were quick to point out that the disappointing season would weigh in heavily on Cineplex’ results.
I took a different view of this and offered a different insight – that while summer traffic was weaker, the usual clustering of blockbusters within a three-month period was now spread out over a longer period. Three of the most anticipated blockbusters of 2017 were released outside of that window, and as a result, reflected outside the quarterly earnings for that period. Justice League, Thor: Ragnarok and Star Wars: The Last Jedi were all released in the fall period before Christmas.
A similar approach seems to be at play this year, with The Black Panther already surpassing the US$300 million mark in February and likely to continue to top box office charts for at least a few weeks. Other blockbusters slated for later this year, including Avengers: Infinity Wars and Deadpool 2 will continue to keep movie-goers interested.
Should you invest in Cineplex?
Following the lower-than-expected results from the summer season, Cineplex reported on the latest quarter this month, which told a completely different story. Revenues in the quarter witnessed a 10.6% increase, which was incredible given that attendance was down by over 2% in the same period.
Cineplex also has an impressive monthly dividend that provides investors with a solid 5.01% yield, making this a great buy-and-forget holding.
Motley Fool Canada's market-beating team has just released a brand-new FREE report revealing 5 "dirt cheap" stocks that you can buy today for under $49 a share.
Our team thinks these 5 stocks are critically undervalued, but more importantly, could potentially make Canadian investors who act quickly a fortune.
Don't miss out! Simply click the link below to grab your free copy and discover all 5 of these stocks now.
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.
Fool contributor Demetris Afxentiou has no position in any stocks mentioned.